共 50 条
- [1] Selinexor demonstrates anti-tumor efficacy in paired patient-derived xenograft models and hydrogel-embedded histoculture drug sensitivity test of penile cancer[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 6931 - 6941He, Yuanqiao论文数: 0 引用数: 0 h-index: 0机构: Nanchang Univ, Ctr Lab Anim Sci, Nanchang 330031, Peoples R China Jiangxi Prov Key Lab Lab Anim, Nanchang 330031, Peoples R China Nanchang Royo Biotechnol, Nanchang 330006, Peoples R China Nanchang Univ, Ctr Lab Anim Sci, Nanchang 330031, Peoples R ChinaMei, Jiaqi论文数: 0 引用数: 0 h-index: 0机构: Nanchang Univ, Clin Med Coll 1, Nanchang 330031, Peoples R China Nanchang Univ, Ctr Lab Anim Sci, Nanchang 330031, Peoples R ChinaHao, Hua论文数: 0 引用数: 0 h-index: 0机构: Tongji Univ, Yangpu Hosp, Sch Med, Dept Pathol, Shanghai 200090, Peoples R China Nanchang Univ, Ctr Lab Anim Sci, Nanchang 330031, Peoples R ChinaLiu, Fanrong论文数: 0 引用数: 0 h-index: 0机构: Nanchang Univ, Affiliated Hosp 2, Dept Pathol, Nanchang 330000, Peoples R China Nanchang Univ, Ctr Lab Anim Sci, Nanchang 330031, Peoples R ChinaYi, Yun论文数: 0 引用数: 0 h-index: 0机构: Nanchang Univ, Affiliated Hosp 2, Ctr Biobank, Nanchang 330000, Peoples R China Nanchang Univ, Ctr Lab Anim Sci, Nanchang 330031, Peoples R ChinaHu, Chao论文数: 0 引用数: 0 h-index: 0机构: Nanchang Univ, Affiliated Hosp 2, Dept Urol, Nanchang 330000, Peoples R China Nanchang Univ, Ctr Lab Anim Sci, Nanchang 330031, Peoples R ChinaZou, Fangxing论文数: 0 引用数: 0 h-index: 0机构: Nanchang Univ, Affiliated Hosp 2, Dept Urol, Nanchang 330000, Peoples R China Nanchang Univ, Ctr Lab Anim Sci, Nanchang 330031, Peoples R ChinaLu, Xiongbing论文数: 0 引用数: 0 h-index: 0机构: Nanchang Univ, Affiliated Hosp 2, Dept Urol, Nanchang 330000, Peoples R China Nanchang Univ, Ctr Lab Anim Sci, Nanchang 330031, Peoples R China
- [2] Chlorogenic acid exhibits antitumor effect in patient-derived xenograft models and hydrogel-embedded tissue culture drug susceptibility test of tongue cancer[J]. HELIYON, 2024, 10 (18)Zhu, Jia论文数: 0 引用数: 0 h-index: 0机构: Nanchang Univ, Affiliated Stomatol Hosp, Jiangxi Med Coll, Nanchang, Jiangxi, Peoples R China Jiangxi Prov Key Lab Oral Dis, Nanchang, Jiangxi, Peoples R China Jiangxi Prov Clin Res Ctr Oral Dis, Nanchang, Jiangxi, Peoples R China Nanchang Univ, Affiliated Stomatol Hosp, Jiangxi Med Coll, Nanchang, Jiangxi, Peoples R ChinaMei, Jiaqi论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Dept Hematol, Nanchang, Jiangxi, Peoples R China Nanchang Univ, Univ Clin Med Coll 2, Nanchang, Jiangxi, Peoples R China Nanchang Univ, Affiliated Stomatol Hosp, Jiangxi Med Coll, Nanchang, Jiangxi, Peoples R ChinaHe, Yuanqiao论文数: 0 引用数: 0 h-index: 0机构: Nanchang Royo Biotech Co Ltd, Nanchang, Jiangxi, Peoples R China Nanchang Univ, Ctr Lab Anim Sci, Nanchang, Jiangxi, Peoples R China Nanchang Univ, Affiliated Stomatol Hosp, Jiangxi Med Coll, Nanchang, Jiangxi, Peoples R ChinaZou, Yan论文数: 0 引用数: 0 h-index: 0机构: Nanchang Univ, Affiliated Stomatol Hosp, Jiangxi Med Coll, Nanchang, Jiangxi, Peoples R China Jiangxi Prov Key Lab Oral Dis, Nanchang, Jiangxi, Peoples R China Jiangxi Prov Clin Res Ctr Oral Dis, Nanchang, Jiangxi, Peoples R China Nanchang Univ, Affiliated Stomatol Hosp, Jiangxi Med Coll, Nanchang, Jiangxi, Peoples R ChinaHu, Xiaoping论文数: 0 引用数: 0 h-index: 0机构: Nanchang Univ, Affiliated Stomatol Hosp, Jiangxi Med Coll, Nanchang, Jiangxi, Peoples R China Jiangxi Prov Key Lab Oral Dis, Nanchang, Jiangxi, Peoples R China Nanchang Univ, Affiliated Stomatol Hosp, Jiangxi Med Coll, Nanchang, Jiangxi, Peoples R China
- [3] Varlitinib demonstrates potent antitumor efficacy in patient-derived gastric cancer xenograft models[J]. CANCER RESEARCH, 2016, 76Doi, A. G. Lisa论文数: 0 引用数: 0 h-index: 0Lindmark, Bertil E.论文数: 0 引用数: 0 h-index: 0McHale, Mark论文数: 0 引用数: 0 h-index: 0Hung, Huynh T.论文数: 0 引用数: 0 h-index: 0Ong, Richard论文数: 0 引用数: 0 h-index: 0
- [4] Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models[J]. Journal of Translational Medicine, 10Xianhua Wu论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax SurgeryJingchuan Zhang论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax SurgeryRuheng Zhen论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax SurgeryJing Lv论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax SurgeryLi Zheng论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax SurgeryXinying Su论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax SurgeryGuanshan Zhu论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax SurgeryPaul R Gavine论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax SurgerySongtao Xu论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax SurgeryShaohua Lu论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax SurgeryJun Hou论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax SurgeryYalan Liu论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax SurgeryChen Xu论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax SurgeryYunshan Tan论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax SurgeryLiang Xie论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax SurgeryXiaolu Yin论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax SurgeryDeming He论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax SurgeryQunsheng Ji论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax SurgeryYingyong Hou论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax SurgeryDi Ge论文数: 0 引用数: 0 h-index: 0机构: Zhongshan Hospital,Department of Thorax Surgery
- [5] Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models[J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10Wu, Xianhua论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Thorac Surg, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaZhang, Jingchuan论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca Global R&D, Innovat Ctr China, Shanghai 201203, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaZhen, Ruheng论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Thorac Surg, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaLv, Jing论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca Global R&D, Innovat Ctr China, Shanghai 201203, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaZheng, Li论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca Global R&D, Innovat Ctr China, Shanghai 201203, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaSu, Xinying论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca Global R&D, Innovat Ctr China, Shanghai 201203, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaZhu, Guanshan论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca Global R&D, Innovat Ctr China, Shanghai 201203, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaGavine, Paul R.论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca Global R&D, Innovat Ctr China, Shanghai 201203, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaXu, Songtao论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Thorac Surg, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China论文数: 引用数: h-index:机构:Hou, Jun论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaLiu, Yalan论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaXu, Chen论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaTan, Yunshan论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaXie, Liang论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca Global R&D, Innovat Ctr China, Shanghai 201203, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaYin, Xiaolu论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca Global R&D, Innovat Ctr China, Shanghai 201203, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaHe, Deming论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R ChinaJi, Qunsheng论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca Global R&D, Innovat Ctr China, Shanghai 201203, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China论文数: 引用数: h-index:机构:Ge, Di论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Zhongshan Hosp, Dept Thorac Surg, Shanghai 200032, Peoples R China Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200032, Peoples R China
- [6] Anti-tumor effects of dovitinib in patient-derived gastrointestinal stromal tumor (GIST) xenograft models.[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)Gebreyohannes, Yemarshet Kelemework论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Dept Oncol, Expt Oncol Lab, Leuven, BelgiumVan Looy, Thomas论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Dept Oncol, Expt Oncol Lab, Leuven, BelgiumWozniak, Agnieszka论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Dept Oncol, Expt Oncol Lab, Leuven, BelgiumWellens, Jasmien论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Dept Oncol, Expt Oncol Lab, Leuven, BelgiumLi, Haifu论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Dept Oncol, Expt Oncol Lab, Leuven, BelgiumCornillie, Jasmien论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Dept Oncol, Expt Oncol Lab, Leuven, BelgiumVanleeuw, Ulla论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Dept Oncol, Expt Oncol Lab, Leuven, BelgiumVreys, Lise论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Dept Oncol, Expt Oncol Lab, Leuven, BelgiumSquires, Matthew论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Dept Oncol, Expt Oncol Lab, Leuven, BelgiumRodriguez, Ana-Maria论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Dept Oncol, Expt Oncol Lab, Leuven, BelgiumDebiec-Rychter, Maria论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Dept Oncol, Expt Oncol Lab, Leuven, BelgiumSciot, Raf论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Dept Oncol, Expt Oncol Lab, Leuven, BelgiumSchoffski, Patrick论文数: 0 引用数: 0 h-index: 0机构: Katholieke Univ Leuven, Dept Oncol, Expt Oncol Lab, Leuven, Belgium
- [7] Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer[J]. Breast Cancer Research, 19Natalia Paez Arango论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Surgical OncologyErkan Yuca论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Surgical OncologyMing Zhao论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Surgical OncologyKurt W. Evans论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Surgical OncologyStephen Scott论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Surgical OncologyCharissa Kim论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Surgical OncologyAna Maria Gonzalez-Angulo论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Surgical OncologyFilip Janku论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Surgical OncologyNaoto T. Ueno论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Surgical OncologyDebu Tripathy论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Surgical OncologyArgun Akcakanat论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Surgical OncologyAung Naing论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Surgical OncologyFunda Meric-Bernstam论文数: 0 引用数: 0 h-index: 0机构: The University of Texas MD Anderson Cancer Center,Department of Surgical Oncology
- [8] Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer[J]. BREAST CANCER RESEARCH, 2017, 19Arango, Natalia Paez论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1400 Pressler St, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1400 Pressler St, Houston, TX 77030 USAYuca, Erkan论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1400 Holcombe Blvd,Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1400 Pressler St, Houston, TX 77030 USAZhao, Ming论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1400 Holcombe Blvd,Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1400 Pressler St, Houston, TX 77030 USAEvans, Kurt W.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1400 Holcombe Blvd,Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1400 Pressler St, Houston, TX 77030 USAScott, Stephen论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1400 Holcombe Blvd,Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1400 Pressler St, Houston, TX 77030 USAKim, Charissa论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Genet, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1400 Pressler St, Houston, TX 77030 USAGonzalez-Angulo, Ana Maria论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1400 Pressler St, Houston, TX 77030 USAJanku, Filip论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1400 Holcombe Blvd,Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1400 Pressler St, Houston, TX 77030 USAUeno, Naoto T.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1400 Pressler St, Houston, TX 77030 USATripathy, Debu论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1400 Pressler St, Houston, TX 77030 USAAkcakanat, Argun论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1400 Holcombe Blvd,Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1400 Pressler St, Houston, TX 77030 USANaing, Aung论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1400 Holcombe Blvd,Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1400 Pressler St, Houston, TX 77030 USAMeric-Bernstam, Funda论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1400 Pressler St, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1400 Holcombe Blvd,Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Sheikh Bin Zayed Al Nahyan Inst Personalized Canc, 1400 Pressler Blvd,Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, 1400 Pressler Blvd,Unit 455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1400 Pressler St, Houston, TX 77030 USA
- [9] Evaluation of Trastuzumab Anti-Tumor Efficacy and its Correlation with HER-2 Status in Patient-Derived Gastric Adenocarcinoma Xenograft Models[J]. PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (04) : 947 - 955Chen, Hao论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai 200127, Peoples R China Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai 200127, Peoples R ChinaYe, Qingqing论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Translat Sci Asia & Emerging Market iMed, Shanghai 201203, Peoples R China Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai 200127, Peoples R ChinaLv, Jing论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Translat Sci Asia & Emerging Market iMed, Shanghai 201203, Peoples R China Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai 200127, Peoples R ChinaYe, Peng论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Translat Sci Asia & Emerging Market iMed, Shanghai 201203, Peoples R China Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai 200127, Peoples R ChinaSun, Yun论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Translat Sci Asia & Emerging Market iMed, Shanghai 201203, Peoples R China Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai 200127, Peoples R ChinaFan, Shuqiong论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Translat Sci Asia & Emerging Market iMed, Shanghai 201203, Peoples R China Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai 200127, Peoples R ChinaSu, Xinying论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Translat Sci Asia & Emerging Market iMed, Shanghai 201203, Peoples R China Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai 200127, Peoples R ChinaGavine, Paul论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Translat Sci Asia & Emerging Market iMed, Shanghai 201203, Peoples R China Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai 200127, Peoples R ChinaYin, Xiaolu论文数: 0 引用数: 0 h-index: 0机构: AstraZeneca R&D, Dept Translat Sci Asia & Emerging Market iMed, Shanghai 201203, Peoples R China Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Gen Surg, Shanghai 200127, Peoples R China
- [10] Anti-tumor efficacy of CKD-702 in EGFR TKI-resistant patient-derived xenograft model[J]. CANCER RESEARCH, 2020, 80 (16)Shin, Jung-Young论文数: 0 引用数: 0 h-index: 0机构: Catholic Univ Korea, Seoul, South Korea Catholic Univ Korea, Seoul, South KoreaKim, Min-Young论文数: 0 引用数: 0 h-index: 0机构: Catholic Univ Korea, Seoul, South Korea Catholic Univ Korea, Seoul, South KoreaLee, Mi-Ran论文数: 0 引用数: 0 h-index: 0机构: Catholic Univ Korea, Seoul, South Korea Catholic Univ Korea, Seoul, South KoreaKim, Jeong-Oh论文数: 0 引用数: 0 h-index: 0机构: Catholic Univ Korea, Seoul, South Korea Catholic Univ Korea, Seoul, South KoreaJeon, Eun-Ju论文数: 0 引用数: 0 h-index: 0机构: CKD Res Inst, Yongin, South Korea Catholic Univ Korea, Seoul, South KoreaChoi, Ji Hye论文数: 0 引用数: 0 h-index: 0机构: CKD Res Inst, Yongin, South Korea Catholic Univ Korea, Seoul, South KoreaHong, Soon-Ki论文数: 0 引用数: 0 h-index: 0机构: CKD Res Inst, Yongin, South Korea Catholic Univ Korea, Seoul, South KoreaPark, Kyu-Jin论文数: 0 引用数: 0 h-index: 0机构: CKD Res Inst, Yongin, South Korea Catholic Univ Korea, Seoul, South KoreaKang, Jin Hyoung论文数: 0 引用数: 0 h-index: 0机构: Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea Catholic Univ Korea, Seoul, South Korea